Core Viewpoint - The AI healthcare and pharmaceutical sectors are experiencing significant upward momentum, with multiple stocks reaching their daily limit up. Group 1: Stock Performance - Chinese Health (301408) and Sichuang Medical (300078) both hit the 20% daily limit up [1] - Other stocks such as Xin Ganjiang, Boji Pharmaceutical (300404), Nossger (301333), Puris (301257), and Dian Diagnostics (300244) also reached their daily limit up [1] - Companies like Okon Pharmaceutical, Rongchang Bio, Weining Health (300253), and BGI Genomics (300676) saw their stock prices increase by over 10% [1]

Group 1 - The core viewpoint of the article highlights the significant rise in the stock price of Dean Diagnostics, which has achieved a three-day consecutive limit-up, indicating strong market interest in AI applications in the healthcare and pharmaceutical sectors [1] - Dean Diagnostics' stock reached a limit-up at 9:35 AM with a trading volume of 1.197 billion yuan and a turnover rate of 7.64%, reflecting high investor activity [1] - The recent surge in the AI healthcare and pharmaceutical sector is attributed to technological breakthroughs that have increased market attention on the application value of AI in these fields [1] Group 2 - The company is actively advancing its technological innovations and market expansion in precision medicine, which has garnered significant industry attention [1]